IFNG and neoplasm: Similarly, Dhodapkar et al. demonstrated that in progressive MM, iNKTs are still detectable in the blood and tumor microenvironment but they have a profound deficiency in their IFN-γ production while in MGUS (monoclonal gammopathy of unknown significance) patients, the deficiency was potentially reversible [16].